The American College of Rheumatology (ACR) has issued a summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis. This is the ACR’s first lupus nephritis guideline since 2012.
Lupus nephritis occurs in people with lupus when autoantibodies affect the kidneys, causing inflammation that may result in scarring. This can lead to blood or protein in the urine, high blood pressure, poor kidney function, or kidney failure.
The new guideline will provide evidence-based, expert guidance for screening, treating, and managing lupus nephritis in adults and, for the first time, in children. Guideline recommendations are based on systematic evidence reviews, values and preferences from a lupus nephritis patient panel, and input from adult and pediatric rheumatologists and nephrologists and a rheumatology physician assistant.
The guideline summary provides 41 recommendations and good practice statements. The ACR expects that the full guideline manuscript will be published in its journals Arthritis Care & Research and Arthritis & Rheumatology in 2025.
Source: Press release
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.